Viatris, Inc. (VTRS)
11.53
-0.13
(-1.11%)
USD |
NASDAQ |
Dec 16, 12:17
Viatris Research and Development Expense (TTM): 886.70M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.13B |
| Amgen, Inc. | 6.828B |
| BioCryst Pharmaceuticals, Inc. | 173.40M |
| Indivior PLC | 94.00M |
| Moderna, Inc. | 3.271B |